287
Participants
Start Date
October 7, 2016
Primary Completion Date
January 9, 2019
Study Completion Date
January 9, 2019
Ergoferon
For oral use.
Placebo
For oral use.
Karaganda State Medical University, Karaganda
"Federal State Budgetary Educational Institution of Higher Education Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation", Moscow
"Limited Liability Company Diagnostics and Vaccines", Moscow
Yaroslavl State Medical University/Children's Clinic # 5, Yaroslavl
Yaroslavl State Medical University/Clinical Hospital # 8, Yaroslavl
"St. Petersburg State Budgetary Health Care Institution Сity Polyclinic №44", Moscow
Volgograd State Medical University, Volgograd
"Federal State Budgetary Educational Institution of Higher Education Kazan Medical University of the Ministry of Healthcare of the Russian Federation", Kazan'
"State Budgetary Institution of Healthcare of the Samara Region Samara City Children's Clinical Hospital named after N.N. Willow New", Samara
"Municipal Health Care Institution City Child Health Clinical Polyclinic №5", Perm
"Municipal autonomous institution Children's City Clinical Hospital №11", Yekaterinburg
Kazakh Medical Continuing Education University, Almaty
Astana Medical University, Astana
Lead Sponsor
Materia Medica Holding
INDUSTRY